Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 7.12 Billion | USD 15.17 Billion | 8.76% | 2023 |
The global veterinary infectious disease diagnostics market size accrued earnings worth approximately USD 7.12 Billion in 2023 and is predicted to gain revenue of about USD 15.17 Billion by 2032, is set to record a CAGR of nearly 8.76% over the period from 2024 to 2032.
The report covers forecast and analysis for the Veterinary Infectious Disease Diagnostics market on a global and regional level. The study provides historic data from 2018 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes drivers and restraints for the Veterinary Infectious Disease Diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Veterinary Infectious Disease Diagnostics market on global as well as regional levels.
In order to give the users of this report a comprehensive view of the Veterinary Infectious Disease Diagnostics market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides a company market share analysis in order to give a broader overview of the key players in the Veterinary Infectious Disease Diagnostics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the Veterinary Infectious Disease Diagnostics market on a global and regional basis.
The Veterinary Infectious Disease Diagnostics Market is a specialized segment within the veterinary healthcare industry focused on the development, production, and distribution of diagnostic tools and tests used to detect infectious diseases in animals. This market addresses the growing need for accurate and timely diagnosis of diseases in livestock, pets, and wildlife, helping to prevent and control outbreaks. It encompasses various diagnostic technologies, including PCR, ELISA, and rapid tests, which enable veterinarians to identify pathogens and infections, ensuring effective treatment and management. The market is driven by increasing pet ownership, rising awareness of animal health, technological advancements, and the need for early detection of zoonotic diseases that can impact both animals and humans.
The Veterinary Infectious Disease Diagnostics Market is witnessing significant growth due to several key factors:
Rising Incidence of Infectious Diseases in Animals: The increasing prevalence of infectious diseases among livestock, companion animals, and wildlife is a major driver of the market. Diseases such as avian influenza, canine parvovirus, and bovine tuberculosis require timely and accurate diagnostics to prevent outbreaks, driving demand for advanced diagnostic tools.
Growing Pet Ownership and Expenditure: The surge in pet ownership, particularly in developed regions, is fueling the demand for veterinary care, including diagnostics. Pet owners are increasingly willing to spend on the health and well-being of their animals, leading to higher demand for veterinary infectious disease diagnostics.
Technological Advancements in Diagnostics: Innovations in diagnostic technologies, such as PCR, ELISA, and next-generation sequencing (NGS), have enhanced the accuracy, speed, and ease of diagnosing infectious diseases in animals. These advancements are helping veterinarians to identify and treat infections more effectively, contributing to market growth.
Increasing Awareness and Preventive Measures: There is a growing awareness among livestock producers and pet owners about the importance of early diagnosis and prevention of infectious diseases. Governments and veterinary organizations are also promoting regular screening and vaccination programs, further boosting the demand for diagnostic services.
Expansion of Veterinary Laboratories: The expansion and modernization of veterinary diagnostic laboratories, particularly in emerging economies, are providing greater access to advanced diagnostic services. This is enabling better disease management and control, thereby driving market growth.
Regulatory Support and Funding: Governments and international organizations are increasingly supporting veterinary diagnostics through funding and favorable regulations. This support is helping to develop and distribute diagnostic tools more widely, especially in regions prone to zoonotic diseases.
Impact of Zoonotic Diseases: The growing concern over zoonotic diseases, which can be transmitted between animals and humans, is driving the need for robust veterinary diagnostics. Effective monitoring and control of such diseases are crucial for public health, further emphasizing the importance of the veterinary infectious disease diagnostics market.
These factors collectively contribute to the robust growth of the Veterinary Infectious Disease Diagnostics Market, as the need for early detection and effective management of animal diseases becomes increasingly critical.
The study provides a decisive view of the Veterinary Infectious Disease Diagnostics market by segmenting the market based on technology, animal type, end-user, and region.
Based on technology, the market is divided into Immunodiagnostics, Molecular Diagnostics, and Other Veterinary Diagnostic Technologies. The Immunodiagnostics segment is sub-segmented into Lateral Flow Assays, ELISA Tests, and Other Immunodiagnostic Technologies. The Molecular Diagnostics segment is sub-segmented into Polymerase Chain Reaction (PCR) Tests, Microarrays, and Other Molecular Diagnostic Tests.
Based on the animal type market is segmented into Food-Producing Animals and Companion Animals.
Different end-users of the market include Veterinary Laboratories and Clinics, Reference Laboratories, Research Institutes, and Universities' Point of Care / In House Testing.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, with its further bifurcation into major countries including the U.S., Canada, China, UK, France, Germany, Japan, India, and Brazil.
This segmentation includes demand for Veterinary Infectious Disease Diagnostics based on individual segment and applications in all the regions and countries.
Report Attributes | Report Details |
---|---|
Report Name | Veterinary Infectious Disease Diagnostics Market |
Market Size in 2023 | USD 7.12 Billion |
Market Forecast in 2032 | USD 15.17 Billion |
Growth Rate | CAGR of 8.76% |
Number of Pages | 110 |
Key Companies Covered | IDEXX Laboratories, Inc., Zoetis, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Neogen Corporation, Virbac, BioMérieux SA, IDVet, Randox Laboratories, Ltd., Heska Corporation, Creative Diagnostics, and Eurofins Technologies and many others |
Segments Covered | By Technology , By Animal Type, By End Users and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Some of the key players in this market are:
FrequentlyAsked Questions
The Veterinary Infectious Disease Diagnostics Market is a specialized segment within the veterinary healthcare industry focused on the development, production, and distribution of diagnostic tools and tests used to detect infectious diseases in animals.
The increasing prevalence of infectious diseases among livestock, companion animals, and wildlife is a major driver of the market. Diseases such as avian influenza, canine parvovirus, and bovine tuberculosis require timely and accurate diagnostics to prevent outbreaks, driving demand for advanced diagnostic tools.
According to a study, the global veterinary infectious disease diagnostics Industry size was $7.12 Billion in 2023 and is projected to reach $15.17 Billion by the end of 2032.
The global veterinary infectious disease diagnostics market is expected to grow at a CAGR of 8.76% during the forecast period.
Some of the key players in this market are: IDEXX Laboratories, Inc., Zoetis, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Neogen Corporation, Virbac, BioMérieux SA, IDVet, Randox Laboratories, Ltd., Heska Corporation, Creative Diagnostics, and Eurofins Technologies and many others.
The global veterinary infectious disease diagnostics market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed